Skip to main content

European Cannabis Holdings Closes Private Round

£3M GBP / $5m CAD Funding Will Be Used to Build on its Existing Portfolio and Prepare for an Early 2019 IPO in London

Extensive Global Experience of Board and Management Reflect Commitment to UK and European Markets

Strategic Investments Will Reinforce the Group's Reputation at the Forefront of Europe's Medical Cannabis Industry

LONDON, UK / ACCESSWIRE / October 18, 2018 / UK based medical cannabis investment group, European Cannabis Holdings (ECH), has announced the completion of its initial round of funding. This will enable the company to deploy more capital into 'ancillary' platforms, data and brands - all of which have been identified as having significant upside potential over the next 12-18 months.

ECH is already a firmly established company within the industry through its stakes in two of the leading European platforms in the space: market intelligence firm, Prohibition Partners, and conference organiser, Cannabis Europa. These strategic investments provide ECH with a fundamental anchor in the European investment market.

The private raise will also prepare ECH for an early 2019 IPO and aggressive growth through improved access to capital markets, a broadened ownership base and wide brand recognition.

In addition, ECH has appointed the successful and widely respected investor and entrepreneur, Jeremy Edelman, to chairman of the board. Jeremy will be joined by Andy DeFrancesco, the founding investor of multiple publicly listed companies including Aphria, Scythian Biosciences and Liberty Health Sciences; and Professor Mike Barnes; a consultant neurologist and prolific proponent and expert on medical cannabis. ECH founding partners, Rob Reid and Ben Langley, make up the remainder of the board.

ECH has also made the following appointments:

  • Stephen Murphy as Chief Insights Officer; The third founder of ECH, managing director of Prohibition Partners and well respected voice in the medical cannabis industry
  • Dean Friday as Chief Financial Officer; A commercially focussed CFO with extensive experience of capital markets and taking businesses though periods of high growth
  • Fraser McGee as Chief Legal Officer; A corporate finance lawyer with over 20 years' experience of private and public markets
  • Hannah Simon as Chief Operating Officer; Experience working for Morgan Stanley and Ernst & Young specialising in operational excellence and delivering improved strategic outcomes for a wider range of private and public organisations
  • Jonathan Nadler as Chief Digital Officer; A brand and digital leader with extensive experience in driving strategy and digital product development for a wide range of international companies and brands

"We are delighted to have closed the private round so quickly. It's indicative of the excitement and buzz surrounding the industry and of course ECH's leadership position in Europe," according to CEO and co-founder, Rob Reid.

"We have a clear vision, a deep partnership with our investors and most importantly an exceptionally talented team in London and Toronto."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: European Cannabis Holdings



View source version on accesswire.com:
https://www.accesswire.com/525746/European-Cannabis-Holdings-Closes-Private-Round

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.